-
Product Insights
Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016" provides an overview of Alpha- Antitrypsin Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha- Antitrypsin Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Fabry Disease Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Fabry Disease Global Clinical Trials Review, H2, 2016" provides an overview of Fabry Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Fabry Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cystinosis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H2, 2016" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
EpiCast Report: Hyperparathyroidism – Epidemiology Forecast to 2025
HPT is a disorder of the parathyroid gland that is caused due to presence of excessive parathyroid hormone (PTH) in the bloodstream. An increase in the activity of parathyroid glands, due to intrinsic abnormal changes, causes alteration of the excretion of PTH, and is known as PHPT. However, an extrinsic abnormal change affecting calcium homoeostasis, which stimulates production of PTH, is known as SHPT. In THPT, a state of autonomous secretion of PTH usually occurs as a result of longstanding...
-
Product Insights
Pompe Disease Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2016" provides an overview of Pompe Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Diabetic Macular Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Diabetic Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016" provides an overview of Familial Chylomicronemia (Type I Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Familial Chylomicronemia (Type I Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Peripheral Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Peripheral Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Hyperbilirubinemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hyperbilirubinemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperbilirubinemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperbilirubinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hyperinsulinemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hyperinsulinemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperinsulinemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperinsulinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.